Skip to main content
. 2018 Aug 10;46(2):312–323. doi: 10.1007/s00259-018-4111-3

Table 2.

Changes in diagnosis after disclosure of the amyloid PET results

Change in clinical diagnosis (%) Change in [18F]FDG PET diagnosis (%) Clinical vs. [18F]FDG PET
All patients (n = 84) 23 18 n.s.
Early onset (≤65 years; n = 36) 22 11 n.s.
Late onset (>65 years; n = 48) 23 23 n.s.
 Early vs. late onset n.s. n.s. (p = 0.158)
Late onset, AUC consistent (n = 33) 21 24 n.s.
Late onset, not AUC consistent (n = 15) 27 20 n.s.
 Late onset, consistent vs. not consistent n.s. n.s.

AUC Appropriate Use Criteria, n.s. not significant